Nipradolol

CAS : 81486-22-8

Ref. 3D-GDA48622

Informations sur le produit

• Nom: Nipradolol
• Synonymes: 2H-1-Benzopyran-3-ol, 3,4-dihydro-8-(2-hydroxy-3-((1-methylethyl)amino)propoxy)-, 3-nitrate, 3,4-Dihydro-8-(2-hydroxy-3-((1-methylethyl)amino)propoxy)-2H-1-benzopyran-3-ol 3-nitrate, 3,4-Dihydro-8-(2-hydroxy-3-(isopropylamino)propoxy)-2H-1-benzopyran-3-ol 3-nitrate, 3,4-Dihydro-8-(2-hydroxy-3-isopropylamino)propoxy-3-nitroxy-2H-1-benzopyran, 8-(2-Hydroxy-3-(isopropylamino)propoxy)-3-chromanol 3-nitrate, 8-(2-Hydroxy-3-(isopropylamino)propoxy)-3-chromanyl nitrat, 8-[2-hydroxy-3-(propan-2-ylamino)propoxy]-3,4-dihydro-2H-chromen-3-yl nitrate, Brn 3566879, Ccris 2515, Hypadil, K 351, Kt 210, Nipradilol [INN:JAN], Nipradilolum, Nipradilolum [Latin], Unii-Fvm336I71Y

Description

Nipradolol is a selective β-adrenergic receptor antagonist. It is used to treat bowel diseases, including constipation and diarrhea. Nipradolol has been shown to inhibit the release of cytosolic Ca2+ in intestinal cells by inhibiting the activity of sodium-dependent glucose co-transporter 1 (SGLT1). Nipradolol has also been shown to have antimicrobial activity against bacteria such as Escherichia coli, Salmonella enterica, and Staphylococcus aureus. This drug may be used for the treatment of inflammatory bowel disease (IBD) or other intestinal disorders induced by ischemia reperfusion. Nipradolol can also be used for cardiac prophylaxis in high-risk patients undergoing noncardiac surgery. The drug inhibits cardiac ion channels and blocks the action of catecholamines on these channels. This agent has also been found to be useful for fetal bov

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 326.34 g/mol
• Formule: C₁₅H₂₂N₂O₆
• Degré de pureté: Min. 95%